Cholestasis-induced pruritus treated with ultraviolet B phototherapy: An observational case series study

Autor: Decock, Sofie, Roelandts, Rik, Steenbergen, Werner Van, Laleman, Wim, Cassiman, David, Verslype, Chris, Fevery, Johan, Pelt, Jos Van, Nevens, Frederik

Publikováno v: In Journal of Hepatology September 2012 57(3):637-641

Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts.

Autor: Bulle, Ashenafi, Dekervel, Jeroen, Deschuttere, Lise, Nittner, David, Cutsem, Eric Van, Verslype, Chris, Pelt, Jos van

Publikováno v: OncoTargets & Therapy; Jul2020, Vol. 13, p6907-6916, 10p

Protective effect of kombucha on rats fed a hypercholesterolemic diet is mediated by its antioxidant activity.

Autor: Bellassoued, Khaled, Ghrab, Ferdaws, Makni-Ayadi, Fatma, Pelt, Jos Van, Elfeki, Abdelfattah, Ammar, Emna

Publikováno v: Pharmaceutical Biology; Nov2015, Vol. 53 Issue 11, p1699-1709, 11p

The use of tuna industry waste in the practical diets of juvenile Nile tilapia ( Oreochromis niloticus, L.): effect on growth performance, nutrient digestibility and oxidative status S A Saïdi et al. Evaluation of waste tuna meal in tilapia diets.

Autor: Saïdi, Saber Abdelkader, Azaza, Mohamed Salah, Abdelmouleh, Abdelwaheb, Pelt, Jos van, Kraïem, Mohamed Mejdeddine, El-Feki, Abdelfattah

Publikováno v: Aquaculture Research; Nov2010, Vol. 41 Issue 12, p1875-1886, 12p, 5 Charts, 2 Graphs

Stabilization of Hypoxia-Inducible Factors and BNIP3 Promoter Methylation Contribute to Acquired Sorafenib Resistance in Human Hepatocarcinoma Cells.

Autor: Méndez-Blanco C; Institute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, 24071 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain., Fondevila F; Institute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, 24071 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain., Fernández-Palanca P; Institute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, 24071 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain., García-Palomo A; Service of Oncology, Complejo Asistencial Universitario de León, Calle Altos de Nava, s/n, 24001 León, Spain., Pelt JV; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven and University Hospitals Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Verslype C; Laboratory of Clinical Digestive Oncology, Department of Oncology, KU Leuven and University Hospitals Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., González-Gallego J; Institute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, 24071 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain., Mauriz JL; Institute of Biomedicine (IBIOMED), University of León, Campus of Vegazana s/n, 24071 León, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Av. de Monforte de Lemos, 5, 28029 Madrid, Spain.

Publikováno v: Cancers [Cancers (Basel)] 2019 Dec 09; Vol. 11 (12). Date of Electronic Publication: 2019 Dec 09.